slides · global inventory
Other
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 19,048
Current window 6,691-6,720
Pages 635
Rows per page 30
Slide type
6,691-6,720 of 19,048
10
The slide uses a process-like flow to connect disease states to specific clinical data and future opportunities.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
12
The diagram is a variation of a flywheel or infinity loop process.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
13
The slide uses a biological neuron metaphor to illustrate a business platform strategy.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
17
The slide uses a numbered list to explain a biological process (pinocytosis, binding, rescue, release) mapped to a visual diagram.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
18
The slide uses a numbered process/comparison flow to contrast binding modes.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
19
The chart shows that Efgartigimod maintains FcRn volume similar to 'No treatment', whereas the 'Control anti-FcRn mAb' causes a significant reduction in volume over time.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
20
The slide uses a causal flow diagram to explain the mechanism of action.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
26
The slide uses a circular process flow to explain the pathology of Immune-Mediated Necrotizing Myopathy (IMNM).argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
27
The slide uses a process-flow framework to show how autoantibodies trigger specific biological pathways (myolysis, capillary disruption, interferon production) leading to muscle atrophy.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
28
The diagram illustrates a hub-and-spoke model where the autoantibody is the central mediator.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
34
Includes two dot plots showing grip/muscle strength and two microscopy images showing necrosis and complement deposition.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
40
The slide depicts a step-by-step biological pathway (1-6) showing how autoantibodies lead to blister formation. It also highlights the therapeutic target Efgartigimod.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
45
Clinical trial design diagram showing a 1:1 randomization between Efgartigimod and Placebo over 36 weeks.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
56
The slide uses a timeline-like structure to show dose escalation cohorts for IV and SC administration.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
60
The chart compares three dosing regimens (60mg/kg LD + 10mg/kg Q2W, 40mg/kg Q4W, 60mg/kg Q8W) against a 99% reduction threshold.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
64
The slide uses immunofluorescence microscopy to demonstrate the efficacy of ARGX-117 in preventing complement-mediated damage.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
65
The slide uses a visual gradient to represent dose-dependency in a biological assay.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
67
The slide uses a process flow diagram to illustrate the clinical trial stages.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
06
The slide uses a process-like flow to connect disease categories to specific autoantibody findings and clinical trial/regulatory status.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The diagram is a variation of a flywheel or infinity loop representing a virtuous cycle of innovation.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
10
The slide uses a biological metaphor (neuron) to represent corporate strategy and portfolio integration.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
12
The slide uses a three-column layout to highlight different patient engagement platforms.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · Financials1 hit
14
The slide uses a split-screen layout to contrast US regulatory progress with international (Japan, EU, China) progress.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations 1 hit
06
The slide uses a table to categorize pipeline progress into regulatory approvals, submissions, and phase III data readouts.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
19
Includes a table of revenue by product and a list of reporting milestones.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The slide uses a vertical axis to represent revenue tiers (Software Licensing, Clinical Services, Value Based Care) and maps specific product features to these tiers.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Solution1 hit
54
This is a complex system architecture diagram showing the integration of various platform layers, services, and security protocols.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank 1 hit
60
The slide uses a brain metaphor to categorize AI capabilities into Clinical Knowledge, Perception, Deep Learning, and Causal AI.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank 1 hit
65
The slide uses a causal graph structure to explain how specific inputs (Immunosuppressed) lead to specific outcomes (Gastroenteritis) through a network of risk factors and disease states.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank 1 hit
71
Uses a process-flow diagram to map geographic markets to product lines and customer types.Babylon | SPAC Presentation Deck | 100 slides · Babylon
Conference presentation Investment bank Beat · Financials1 hit